Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Watson Pharmaceuticals Inc Acquires Uteron Pharma SA


Tuesday, 22 Jan 2013 07:00pm EST 

Watson Pharmaceuticals Inc announced that it has completed the acquisition of Belgium-based Uteron Pharma SA (Uteron) for USD 150 million in cash up front, and up to USD 155 million in potential future payments. Uteron's executive team will continue to manage Uteron. 

Company Quote

0.59
-0.01 -1.67%
14 Jul 2014